Skip to main content

Table 2 Demographic data of individuals tested for Trypanosoma cruzi infection in Germany and the years 2000–2018

From: Describing nearly two decades of Chagas disease in Germany and the lessons learned: a retrospective study on screening, detection, diagnosis, and treatment of Trypanosoma cruzi infection from 2000 – 2018

Sex Female
n = 2389/5991
39.9%
Male
n = 2365/5991
39.5%
Unknown
n = 1237/5991
20.6%
All
n = 5991
100.0%
Age at time of testing Data on age available on 2312/2389 (96.8%)
n = 2312
Data on age available on 2322/2365 (98.2%)
n = 2322
Data on age available on
277/1237 (22.4%)
n = 277
Data on age available on 4911/5991 (82.0%)
n = 4911
 Mean (SD) 37.4 years (SD = 16.0) 41.2 years (SD = 16.6) 35.4 years (SD = 21.3) 39.1 years (SD = 16.7)
 ≤14 78 (3.4%) 87 (3.7%) 67 (24.2%) 232 (4·7%)
 15–49 1695 (73.3%) 1474 (63.5%) 146 (52.7%) 3315 (67.5%)
 ≥50 539 (23.3%) 761 (32.8%) 64 (23.1%) 1364 (27.8%)
Nationality Data on nationality available on
417/2389 (17.5%) n = 417
Data on nationality available on
378/2365 (16.0%) n = 378
Data on nationality available on
19/1237 (1.5%) n = 19
Data on nationality available on
814/5991 (13.6%) n = 814
 Argentina 7 (1.7%) 0 0 7 (0.9%)
 Bolivia 18 (4.3%) 13 (3.4%) 0 31 (3.8%)
 Brazil 24 (5.8%) 9 (2.4%) 3 (15.8%) 36 (4.4%)
 Colombia 11 (2.6%) 2 (0.5%) 0 13 (1.6%)
 Costa Rica 1 (0.2%) 0 0 1 (0.1%)
 Ecuador 4 (1.0%) 4 (1.1%) 0 8 (1.0%)
 El Salvador 1 (0.2%) 0 0 1 (0.1%)
 Guatemala 1 (0.2%) 0 0 1 (0.1%)
 Mexico 5 (1.2%) 0 0 5 (0.6%)
 Nicaragua 1 (0.2%) 0 0 1 (0.1%)
 Panama 0 1 (0.3%) 0 1 (0.1%)
 Paraguay 5 (1.2%) 2 (0.5%) 0 7 (0.9%)
 Peru 6 (1.4%) 6 (1.6%) 0 12 (1.5%)
 Venezuela 4 (1.0%) 1 (0.3%) 1 (5.3%) 6 (0.7%)
 Germany 297 (71.2%) 318 (84.1%) 12 (63.2%) 627 (77.0%)
 Other non-endemic countries 32 (7.7%) 22 (5.8%) 3 (15.8%) 57 (7.0%)
  1. SD Standard deviation